Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000301
Chunk: 107

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 107
---
 |     | July 1, 2025              |     | $ |    60,000 |     | $ |           1,668.49 |     | $ |   61,668.49 |
| 31            |     | August 1, 2025            |     | $ |    60,000 |     | $ |           1,528.77 |     | $ |   61,528.77 |
| 31            |     | September 1, 2025         |     | $ |    60,000 |     | $ |           1,273.97 |     | $ |   61,273.97 |
| 30            |     | October 1, 2025           |     | $ |    60,000 |     | $ |             986.30 |     | $ |   60,986.30 |
| 33            |     | November 3, 2025          |     | $ |    60,000 |     | $ |             813.70 |     | $ |   60,813.70 |
| 28            |     | December 1, 2025          |     | $ |    60,000 |     | $ |             460.27 |     | $ |   60,460.27 |
| 22            |     | Issuance Date Anniversary |     | $ |    60,000 |     | $ |             180.82 |     | $ |   60,180.82 |
|               |     |                           |     | $ |   600,000 |     | $ |          19,372.60 |     | $ |  619,372.60 |

| (1) | Estimated Accrued and Unpaid Interest. Actual amount may differ on an applicable Installment Date. |

<div align='center'>ANNEX A
REPRESENTATIONS AND WARRANTIES OF THE COMPANY</div>

The Company represents and
warrants to the Holder that as of the Issuance the Note:

(a) . The Company and each of its Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite corporate power and authority
to own and use its properties and assets and to carry on its business as currently conducted. Each of